37
Accepted manuscripts are peer-reviewed but have not been through the copyediting, formatting, or proofreading process. Copyright © 2016 the authors This Accepted Manuscript has not been copyedited and formatted. The final version may differ from this version. Research Articles: Behavioral/Cognitive Loss of plasticity in the D2-accumbens pallidal pathway promotes cocaine seeking J.a. Heinsbroek 1,* , D.n. Neuhofer 1,* , W.c. Griffin 2 , G.s. Siegel 2 , A-C Bobadilla 1 , Y.m. Kupchik 3,+ and P.w. Kalivas 1,2, + 1 Department of Neuroscience, Medical University of South Carolina, Charleston, SC 2 Department of Psychiatry and Behavioral Science, Medical University of South Carolina, Charleston, SC 3 Department of Neuroscience, Hebrew University, Jerusalem, Israel DOI: 10.1523/JNEUROSCI.2659-16.2016 Received: 22 August 2016 Revised: 15 November 2016 Accepted: 28 November 2016 Published: 1 December 2016 Author contributions: J.A.H., D.N.N., Y.M.K., and P.W.K designed research; J.A.H., D.N.N., G.W.C., Y.M.K., W.C.G., G.S.S. and B.A-C. performed research; J.A.H., D.N.N., Y.M.K., and P.W.K analyzed data; J.A.H. and P.W.K. wrote the paper. This research was supported in part by USPHS grants DA012512, DA003906 and DA015369. We thank Dr. Jamie Peters and the members of the Kalivas lab for helpful comments on the manuscript, and thank Victoria Charensouk and Lauryn Luderman for technical assistance. Correspondence should be addressed to Jasper Heinsbroek and Peter Kalivas, Medical University of South Carolina, Drug Discovery Building 223, 70 President St, Charleston, SC 29425. Email: [email protected] and [email protected] Cite as: J. Neurosci 2016; 10.1523/JNEUROSCI.2659-16.2016 Alerts: Sign up at www.jneurosci.org/cgi/alerts to receive customized email alerts when the fully formatted version of this article is published.

Loss of plasticity in the D2-accumbens pallidal pathway promotes

  • Upload
    vodang

  • View
    215

  • Download
    0

Embed Size (px)

Citation preview

Accepted manuscripts are peer-reviewed but have not been through the copyediting, formatting, or proofreadingprocess.

Copyright © 2016 the authors

This Accepted Manuscript has not been copyedited and formatted. The final version may differ from this version.

Research Articles: Behavioral/Cognitive

Loss of plasticity in the D2-accumbens pallidal pathway promotes cocaine seeking

J.a. Heinsbroek1,*, D.n. Neuhofer1,*, W.c. Griffin2, G.s. Siegel2, A-C Bobadilla1, Y.m. Kupchik3,+ and P.w. Kalivas1,2,

+

1Department of Neuroscience, Medical University of South Carolina, Charleston, SC2Department of Psychiatry and Behavioral Science, Medical University of South Carolina, Charleston, SC3Department of Neuroscience, Hebrew University, Jerusalem, Israel

DOI: 10.1523/JNEUROSCI.2659-16.2016

Received: 22 August 2016

Revised: 15 November 2016

Accepted: 28 November 2016

Published: 1 December 2016

Author contributions: J.A.H., D.N.N., Y.M.K., and P.W.K designed research; J.A.H., D.N.N., G.W.C., Y.M.K.,W.C.G., G.S.S. and B.A-C. performed research; J.A.H., D.N.N., Y.M.K., and P.W.K analyzed data; J.A.H. andP.W.K. wrote the paper.

This research was supported in part by USPHS grants DA012512, DA003906 and DA015369. We thank Dr.Jamie Peters and the members of the Kalivas lab for helpful comments on the manuscript, and thank VictoriaCharensouk and Lauryn Luderman for technical assistance.

Correspondence should be addressed to Jasper Heinsbroek and Peter Kalivas, Medical University of SouthCarolina, Drug Discovery Building 223, 70 President St, Charleston, SC 29425. Email: [email protected] [email protected]

Cite as: J. Neurosci 2016; 10.1523/JNEUROSCI.2659-16.2016

Alerts: Sign up at www.jneurosci.org/cgi/alerts to receive customized email alerts when the fully formattedversion of this article is published.

Animals.

ad libitum

Guidelines for the Care and Use of Laboratory Animals.

Surgery.

Cocaine self-administration, extinction and reinstatement.

Sucrose self-administration, extinction and reinstatement.

Slice preparation and Whole-cell patch-clamp recording.

Ω

Histology.

Statistical analysis.

A

A

A t

t

B

A A B; B

A

B

A

B F p F

p F p

up state

A B

C t p

3D,E

F

p

F G t

p

A B

C D

F p

t p

E F

A C

B t p

D t p

5B; t p

D

t p

A

A B

C

F p

t p

D t p

F F p

F p

G

t p t p

E t p t p

H t p

H t p

A B

C D

E F p

F p

F t p

t p

A

B

A

B

A

B

C

C

D

E

p

F

G

A

B

C

D

p

E

F

A B

p

C

D

A

B

C

p D

p

E

p

F

p

G

p

H

p

A

B

C

D

E

p

F

p

120

40

80

120

Lever

Pre

sses (

2h

)

Self-administration

61 1 6

Extinction

10

D1-CreA

NeuN

Gs-DREADDDARPP-32

ac

D

V

M L

BDays

Active Lever Active Lever

Inactive Lever

Infusions Inactive Lever

D2-Cre

0

40

80

120

Lever

Pre

sses (

2h

)

1261 1 6 10

that could contribute to the bidirectional regulation of cocaine seeking!

A

0 5 10 15 200

50

100

150

% C

on

tro

l IP

SC

D1D2

Control

CNO

Time (min)

NAcore

Gi-DREADD

ac ac

dlVP

vmVP

NAcore

ChR2

ac ac

dlVP

vmVP

D

V

A P

B

ac

Met-Enkephalin

Gi-DREADD

D

V

L MCPu

dlVP

BST

IPAC

CNOVeh0

40

80

CNO

NAc Gs-DREADD

NAc Gs-DREADD

*Infusions

Inactive Lever

60

60

0

0

D E

D1-Cre

Vo

lta

ge

Ch

an

ge

(m

V)

-5 0 5 10-10

-5

0

5

Active

Le

ve

r P

resse

s (

2h

)

Time (min)

C

CNO

GFSelf-Admin

Extinction

Cue Test

116

5 7 7n = 8

+ VP Gi-DREADD

Le

ve

r P

resse

s (

2h

)

*Active Lever

CNOVeh

60

60

0

0

Self-Admin

Extinction

Le

ve

r P

resse

s (

2h

)

Gs-DREADD

Cue Test

D2-Cre0

40

80

BA

ic

lv

BST

VP

SI

DBH

LH

ac

cc

f

ac

CPu

dlVP

D

V

M L

Gi-DREADD

Gs-DREADD

Gs-DREADD

Gi-DREADD

NAcore

dlVP

Infusions

Inactive Lever

Active Lever

Active

Le

ve

r P

resse

s (

2h

)

ac

ac

NAcore

NAshell

CPuD

V

A P

dlVP

IPAC

Gi-DREADD

Gi-DREADD

Gi-DREADD

Gi-DREADD

A

B

NAc Gi-DREADD

*

NAc Gi-DREADD

+VP Gi-DREADD

11 6

5

D

CNOVeh0

40

80

CNO

*

60

60

0

0

Self-Admin

Extinction

C

Le

ve

r P

resse

s (

2h

)

D2-Cre

60

60

0

0

E

Le

ve

r P

resse

s (

2h

)

Self-Admin

Extinction

6 6

F

Gi-DREADD

0

40

80

CNOVehD1-Cre

NAcore

dlVP

Infusions

Inactive Lever

Active Lever

Infusions

Inactive Lever

Active Lever

Active

Le

ve

r P

resse

s (

2h

)

Active

Le

ve

r P

resse

s (

2h

)

CNOVeh

6 60

40

80

CNOVeh

6 60

40

80

Cue Test

120

50

100

150

Days

Lever

Pre

sses (

2h)

Self Administration

61

Active Lever

Pellets

Inactive Lever

A

C

1 5 10

Extinction

0

200

400

B

Extinction

D1-Cre

Lever

Pre

sses (

2h)

Self Administration

0

50

100

150

Lever

Pre

sses (

2h)

1261 1 5 10

Days

0

200

400

Lever

Pre

sses (

2h)

D

CNOVeh

5 60

80

160

CNOVeh

4 40

80

160

Sucrose Primed

Cue Test

*

Cue Test

D2-Cre

Sucrose Primed

Cue Test

Active

Le

ve

r P

resse

s (

2h

)

Active

Le

ve

r P

resse

s (

2h

)

Active

Le

ve

r P

resse

s (

2h

)

Active

Le

ve

r P

resse

s (

2h

)

Active Lever

Pellets

Inactive Lever

Active Lever

Inactive Lever

Active Lever

Inactive Lever

B

-5 0 5 10 15

50

100

150

D1D2

C

G

ac

VP

ic

*

NAcore

NAshell

dlVP

A

vmVP

ac

IPAC

**

-5 0 5 10

50

100

D2D1

F

50

100

150

50

100

150

D1 D2

D1 D2

D

0

1

2

**

pre post pre post

E

*

pre post pre post

*

H

8/7 9/5

6/3 9/5

% B

ase

line

IP

SC

Pa

ire

d P

uls

e R

atio

Time (min)

0

1

2

Pa

ire

d P

uls

e R

atio

% B

ase

line

IP

SC

% B

ase

line

IP

SC

% B

ase

line

IP

SC

Time (min)

50 ms

40

0 p

A

50 ms

50

0 p

A

ChR2

40

0 p

A

8/7 9/5

6/5 7/4

50 ms

40

0 p

A

50 ms

HFS

Control

Cocaine

15

HFS

*

A

-5 0 5 10 15

Time (min)

D2

CTOP

HFS

D1

C

50

100

150

200

50

100

150

200E

D

F

B

D1 D2

10/6 5/5

8/7 6/5

Control

% B

ase

line

IP

SC

% B

ase

line

IP

SC

% B

ase

line

IP

SC

% B

ase

line

IP

SC

% B

ase

line

IP

SC

% B

ase

line

IP

SC

-5 0 5 10 15

Time (min)

D1 D2

D2D1

Control

CTOP

-5 0 5 10 15

Time (min)D1 D2

CTOP

D2D1

Cocaine

50

100

150

200

50

100

150

200

25 ms

50

0 p

A

25 ms

50

0 p

A

25 ms

50

0 p

A

50

100

150

200

0

0

50

100

150

200

09/7 12/9

*

*